Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Cushman & Wakefield advises Hines on £380 million 25 Cabot Square Sale

27/07/2020
The London Capital Markets team at Cushman & Wakefield has advised Hines on the £380 million disposal of The Cabot, 25 Cabot Square in Canary Wharf, London to Link REIT.

The London Capital Markets team at Cushman & Wakefield has advised Hines on the £380 million disposal of The Cabot, 25 Cabot Square in Canary Wharf, London to Link REIT.

The 17-storey 481,605 square feet building is located in the heart of Canary Wharf and is let to a number of tenants, including Morgan Stanley and UK government departments. Over the past six years this Grade A asset has undergone extensive refurbishment and extension work which has increased the retail amenities and seen the public realm across the site re-landscaped. 

Martin Lay, Joint Head of London Capital Markets at Cushman & Wakefield, said: “The sale of 25 Cabot Square is the largest deal to have taken place in London this year and demonstrates the green shoots of activity we are seeing in the office market following the COVID-19 lockdown. This landmark deal confirms the enduring appeal of London office assets and the UK as a key destination for overseas investment.”

Andrew Hawkins, International Partner at Cushman & Wakefield, added: “Cushman & Wakefield's London Capital Markets team, along with Hong Kong colleagues, have been working closely with Link REIT for nine months, discussing their entry point into London. We are delighted that they recognised the strong fundamentals of Hines’ development and the excellent growth characteristics of Canary Wharf.”

Link REIT is the largest REIT in Asia and this deal marks their first transaction in the UK and only their second outside of Hong Kong and Mainland China, following their acquisition of 100 Market Street in Sydney, where Cushman & Wakefield also acted on the sell side.


MEDIA CONTACT

Lauren Joselyn Cushman & Wakefield
Lauren Joselyn

Associate Director, EMEA Communications • London

What's new

European Grade A Office Availability Ratio Declines As Occupiers Focus On Best in Class Space
European Grade A Office Availability Ratio Declines As Occupiers Focus On Best in Class Space

Availability of Grade A space demanded by occupiers remains low and below 2% of total office stock in many key markets.

18/11/2022

istockphoto-idea
GSK Completes Sale Of Strategic Life Sciences Development Site

Real estate services firm Cushman & Wakefield has advised GSK plc on the sale of the surplus development land that sits alongside its 1 million sq ft Research & Development (R&D) facility in Stevenage to UBS Asset Management and Reef Group. 

11/11/2022

dna graphic
Research • Investment

DNA of Real Estate

DNA of Real Estate tracks prime rents and yields in up to 45 cities across Europe, covering the key office, high street and logistics sectors. It provides an overview of quarterly performance for prime rents and yields.
Nigel Almond • 21/11/2022
London Big Ben Westminster Bridge sunset
MarketBeat • Insights

UK MarketBeat

Cushman & Wakefield MarketBeat reports analyse quarterly UK commercial property activity across office, retail and industrial real estate sectors as well as the Central London residential market. Find data on supply, demand and pricing trends at the market and submarket levels.
Daryl Perry • 27/10/2022
Oxford Street, London
MarketBeat • Office

Central London MarketBeat

Central London Marketbeat provides an overview of the occupational and investment markets across Central London on a quarterly basis.  

Liberty Strong • 18/08/2022

CAN'T FIND WHAT YOU'RE LOOKING FOR?

Get in touch with one of our professionals.
With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Cookies.
MORE OPTIONS
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS